Alan L Ho

26PUBLICATIONS
230CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

|Mar 04, 2026
Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.

Susan Slovin, Xin Gao, Xiao X Wei

|Jan 28, 2026
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.

Manu Prasad, Alex T Cheng, Marcel Mayer

|Oct 09, 2025
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Anne S Tsao, Zihe Song, Alan L Ho

|Jun 12, 2025
Long-Term Results of External Beam Radiation Therapy with or Without Concurrent Chemotherapy in Differentiated Thyroid Cancer.

Justin Choi, Eric Sherman, Edward Christopher Dee

|May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Dan P Zandberg, Jacob B Allred, Ari J Rosenberg

Pageof 5

Frequent Collaborators

7 joint publications

Luc G T Morris

5 joint publications

Nora Katabi

4 joint publications

James Fagin

4 joint publications

David G Pfister